Cotreatment with SC-79 significantly increased the number of transmigrated cells compared with melittin group, implying Akt activation may reverse the effect of melittin on CoCl2-induced migration of hepatoma cells. The gene discussed is AKT1; the disease is hepatocellular carcinoma.